CapsoVision Inc (CV): Next-Year EPS Estimate 27.08%
As of 2026-05-07, CapsoVision Inc (CV) has a next-year EPS growth estimate of 27.08%.
On 2026-03-29, analyst consensus for CV's next-year EPS growth shifted from 55.10% to 27.08% — a negative change of 28.02 percentage points. The revised estimate has been sustained across 41 subsequent trading sessions. Current-year growth is projected at 53.40%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 27.08%
- EPS growth this year
- 53.40%
- EPS next quarter (est)
- -$0.13
- Last price
- $7.19
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 27.08% | 53.40% | -$0.13 | $7.19 |
| 2026-05-06 | 27.08% | 53.40% | -$0.13 | $7.01 |
| 2026-05-05 | 27.08% | 53.40% | -$0.13 | $7.06 |
| 2026-05-04 | 27.08% | 53.40% | -$0.13 | $7.07 |
| 2026-05-03 | 27.08% | 53.40% | -$0.13 | $7.50 |
| 2026-04-30 | 27.08% | 53.40% | -$0.13 | $7.08 |
| 2026-04-29 | 27.08% | 53.40% | -$0.13 | $6.40 |
| 2026-04-28 | 27.08% | 53.40% | -$0.13 | $6.78 |
| 2026-04-27 | 27.08% | 53.40% | -$0.13 | $6.37 |
| 2026-04-26 | 27.08% | 53.40% | -$0.13 | $6.07 |
| 2026-04-24 | 27.08% | 53.40% | -$0.13 | $6.07 |
| 2026-04-23 | 27.08% | 53.40% | -$0.13 | $5.77 |
| 2026-04-22 | 27.08% | 53.40% | -$0.13 | $5.96 |
| 2026-04-21 | 27.08% | 53.40% | -$0.13 | $5.95 |
| 2026-04-20 | 27.08% | 53.40% | -$0.13 | $6.01 |
| 2026-04-19 | 27.08% | 53.40% | -$0.13 | $6.01 |
| 2026-04-16 | 27.08% | 53.40% | -$0.13 | $5.40 |
| 2026-04-15 | 27.08% | 53.40% | -$0.13 | $5.97 |
| 2026-04-14 | 27.08% | 53.40% | -$0.13 | $6.44 |
| 2026-04-13 | 27.08% | 53.40% | -$0.13 | $6.46 |
| 2026-04-12 | 27.08% | 53.40% | -$0.13 | $6.25 |
| 2026-04-10 | 27.08% | 53.40% | -$0.13 | $6.12 |
| 2026-04-09 | 27.08% | 53.40% | -$0.13 | $6.38 |
| 2026-04-08 | 27.08% | N/A | -$0.13 | $6.14 |
| 2026-04-07 | 27.08% | N/A | -$0.13 | $6.26 |
| 2026-04-06 | 27.08% | N/A | -$0.13 | $6.26 |
| 2026-04-05 | 27.08% | N/A | -$0.13 | $7.44 |
| 2026-04-03 | 27.08% | N/A | -$0.13 | $6.26 |
| 2026-04-02 | 27.08% | N/A | -$0.13 | $6.26 |
| 2026-04-01 | 27.08% | N/A | -$0.13 | $6.26 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is CapsoVision Inc's next-year EPS growth estimate?▾
As of 2026-05-07, CapsoVision Inc (CV) has a next-year EPS growth estimate of 27.08%, based on analyst consensus.
When was the latest EPS estimate revision for CV?▾
The most recent revision occurred on 2026-03-29, when analysts adjusted the next-year EPS growth estimate from 55.10% to 27.08%.
What sector and industry does CapsoVision Inc belong to?▾
CapsoVision Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. CapsoVision Inc (CV) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports